✦ LIBER ✦

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (The FASE Study)

✍ Scribed by Joseph Monsonego; Michael G. Hudgens; Laurent Zerat; Jean-Claude Zerat; Kari Syrjänen; Jennifer S. Smith

Book ID: 113964009
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 184 KB
Volume: 125
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.01.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of oncogenic human papillomav

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study

✍ Joseph Monsonego; Michael G. Hudgens; Laurent Zerat; Jean-Claude Zerat; Kari Syr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB 👁 2 views

The APTIMA V R HPV Assay (AHPV) allows detection of 14 high-risk human papillomavirus (HPV) RNA types in cervical specimens. Until present, the assay has been compared to HPV DNA tests only in triage settings. Herein, we compare AHPV with a DNA assay (Hybrid Capture V R 2; HC2) and liquid-based cyto

Evaluation of primary cervical cancer sc

Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States

✍ Janet G. Baseman; Shalini L. Kulasingam; Tiffany G. Harris; James P. Hughes; Nan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 133 KB